Amrize (NYSE:AMRZ) Insider Jaime Hill Acquires 4,000 Shares of Stock

Amrize Ltd (NYSE:AMRZ) insider Jaime Hill bought 4,000 shares of the business’s stock in a transaction dated Tuesday, November 4th. The stock was purchased at an average price of $50.69 per share, with a total value of $202,760.00. Following the purchase, the insider directly owned 18,101 shares of the company’s stock, valued at $917,539.69. The trade was a 28.37% increase in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.

Jaime Hill also recently made the following trade(s):

• On Friday, August 22nd, Jaime Hill purchased 500 shares of Amrize stock. The shares were acquired at an average cost of $49.59 per share, with a total value of $24,795.00.
• On Friday, August 15th, Jaime Hill bought 4,000 shares of Amrize stock. The stock was acquired at an average price of $51.99 per share, with a total value of $207,960.00.
• On Friday, August 8th, Jaime Hill purchased 4,000 shares of Amrize stock. The stock was acquired at an average cost of $46.40 per share, with a total value of $185,600.00.

Amrize Stock Down 2.1%

Shares of NYSE:AMRZ opened at $49.76 on Friday. Amrize Ltd has a 12 month low of $44.12 and a 12 month high of $56.29. The stock’s 50-day moving average is $50.52. The company has a current ratio of 1.38, a quick ratio of 0.85 and a debt-to-equity ratio of 0.42. The company has a market cap of $27.52 billion and a price-to-earnings ratio of 27.04.

Amrize (NYSE:AMRZ) last announced its earnings results on Wednesday, August 6th. The company reported $0.78 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.03 by ($0.25). The firm had revenue of $3.22 billion for the quarter.

Analyst Ratings Changes

AMRZ has been the subject of several recent research reports. JPMorgan Chase & Co. boosted their price objective on Amrize from $52.00 to $60.00 and gave the stock an “overweight” rating in a report on Tuesday, August 26th. Wells Fargo & Company increased their price objective on shares of Amrize from $57.00 to $58.00 and gave the company an “overweight” rating in a report on Thursday, October 30th. UBS Group raised their price objective on shares of Amrize from $52.00 to $53.00 and gave the company a “neutral” rating in a research note on Monday. Morgan Stanley set a $61.00 target price on shares of Amrize and gave the company an “overweight” rating in a research report on Wednesday, October 29th. Finally, Wall Street Zen upgraded Amrize to a “hold” rating in a research report on Saturday, October 25th. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $58.71.

Hedge Funds Weigh In On Amrize

A number of hedge funds and other institutional investors have recently made changes to their positions in AMRZ. Vanguard Group Inc. bought a new stake in shares of Amrize in the 2nd quarter valued at $1,065,029,000. Norges Bank bought a new position in shares of Amrize during the 2nd quarter valued at about $670,915,000. Dodge & Cox acquired a new position in shares of Amrize in the 2nd quarter valued at approximately $622,085,000. JPMorgan Chase & Co. bought a new stake in Amrize during the 2nd quarter worth approximately $220,404,000. Finally, Legal & General Group Plc acquired a new stake in Amrize during the 2nd quarter worth approximately $161,761,000.

About Amrize

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.